What exactly changed in the ACM analyst rating on Feb 10, 2026?

On Feb 10, 2026 UBS maintained a **Buy** on ACM and raised its price target to **$145** from **$143**, per The Fly. The move keeps UBS's positive stance while slightly increasing upside expectations.

How does UBS’s $145 target compare with other analysts?

UBS's **$145** target is **$18.27** above the MarketWatch consensus target of **126.73**, about **14.42%** higher. That spread shows UBS expects stronger relative performance than the median analyst.

What should investors do after this ACM upgrade news?

Investors should review UBS's assumptions against their own, check consensus data, and consider Aecom's backlog, margins, and recent earnings. Use analyst notes as one input in a diversified process.

What does Meyka AI’s grade mean for ACM investors?

Meyka AI rates ACM **B+** based on benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade is informational and not investment advice.

Analyst Ratings

UBS Maintains Buy on ACM (Aecom) Feb 2026, Price Target Raised to $145

ByHuzaifa Zahoor February 11, 2026February 11, 2026

UBS on Feb 10, 2026 maintained a Buy on ACM (Aecom) and raised its price target to $145. The ACM analyst rating by UBS signals continued conviction in Aecom’s backlog and margins after the Q1 call. Investors should note UBS kept the rating while nudging the target from $143 to $145, a measured move that reflects steady fundamental views rather than a dramatic outlook change. This update ties directly to analyst expectations and broader consensus data.